Cite

HARVARD Citation

    Oldenburg, J. et al. (2019). The effect of emicizumab prophylaxis on health‐related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study. Haemophilia. 25 (1), pp. 33-44. [Online]. 
  
Back to record